Dr. Howard Smith Oncall

Vidcast:  https://www.instagram.com/drhowardsmithreports/reel/DHDxzayvjCg/Treating acute and chronic lung disease like influenza, CoVid, and emphysema is challenging since may therapeutic agents fail to reach the deep and peripheral portions of the lungs.  RNA innovators at the University of Pennsylvania report the development of new mRNA therapy that can do just that.  Housed in a lipid nanoparticle, the mRNA infused directly to the lungs instructs the distant pulmonary tissues to produce proteins that repair damage from CoVid, influenza, and RSV infections. It can also be employed in the battle against lung cancer.This novel approach could yield more targeted treatments for not only pulmonary disease but also other damaged organs. It can also be employed in the battle against lung cancer.https://www.pennmedicine.org/news/news-releases/2025/february/new-mrna-therapy-could-repair-damaged-lungshttps://www.nature.com/articles/s41467-025-56448-y#mRNA #pneumonia #emphysema #CoVid #influenza #rsv